Herbal granules may offer new hope for aging kidneys

NCT ID NCT07741292

First seen Aug 03, 2026 · Last updated Aug 04, 2026 · Updated 1 time

Summary

This study tests whether a traditional Chinese medicine, Niaoduqing granules, can slow the decline of kidney function in adults over 60 with chronic kidney disease. Participants will take the granules three times daily for a year while continuing their usual care. Researchers will track kidney function, nutrition, frailty, and other health outcomes to see if the treatment offers benefits. The study also looks at gut bacteria and blood markers to understand how the granules might work.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Niaoduqing Granules
What this could lead to
If effective, this treatment could slow the progression of chronic kidney disease in older adults, potentially delaying the need for dialysis and improving quality of life.
What could go wrong
This is a real-world study, not a controlled trial, so results may be influenced by other factors. The benefits are uncertain, and the treatment may not work for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Huashan Hospital, Fudan University

    RECRUITING

    Shanghai, Shanghai Municipality, 20040, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.